《中国药物经济学》杂志是由中国农工民主党中央委员会主管，中国中医药研究促进会主办，国家相关部门给予政策指导、全面介绍药物经济学理论知识与实践案例的专业性学术期刊，经国家新闻出版总署批准，2006年6月正式创刊，面向全国公开发行，新编国内统一刊号为：CN 11-5482/R，国际标准连续出版物编码为：ISSN 1673-5846，邮发代号：80-929。
《中国药物经济学》杂志以促进药物经济学在药政管理、医疗保险、新药研发与定价、临床合理用药、药品资源合理配置、临床医学与药学等领域的应用为办刊宗旨。为加大药物经济学的宣传力度，加强社会各界对药物经济学的了解，我社组织大批从事医学、药学、经济学、生物统计学、社会保险学、卫生经济学等研究领域的专业人才，将理论性、知识性、实用性相结合，力求以国际化视野，用经济学的眼光，分析、研究我国药物经济市场，正确指导药物经济学评价体系进入我国卫生领域，是我国药物经济学第一份专业性学术刊物，是社会各界了解药物经济学的最权威窗口。
China Journal of Pharmaceutical Economics is supervised by the Central Committee of The Chinese Peasants and Workers Democratic Party while guided by China Association of Promoting Traditional Medicine and the national relevant departments. It is a academic journal which introduces comprehensive theoretical and practical knowledge of pharmacoeconomics.It was approved by the state Press and Publication Administration to started publication in June 2006,national issueoriented.New Issues of national unity CN 11-5482/R,International Standard Serial Encoder ISSN1673-5846 post distribution code:80-929.
The China Journal of Pharmaceutical Economics aims to promote the application of Pharmacoeconomics in some relevant fields,such as the pharmacy administration and medical insurance.New Drug R &D and pricing, Clinical rational drug use,the rational distribution drug resources,clinical medicine and pharmacy,etc.. In order to give more publicity of Pharmacoeconomics and enhance the understanding of public to pharmacoeconomics we organize a large number of professionals from different fields of medical, pharmacy, economics,biostatistics,social insurance, health economics,etc..trying to combine their theoretical ,intellectual and practical opinions which forms an international point of view;to anaLyze and research the drug market of China in the perspective of Economics; and to provide right guidance to the Pharmacoeconomics Evaluation System for entering into the field of medicine and public health in China. The China Journal of Pharmaceutical Economics is the first major academic publication in the field of pharmacoeconomics in China which would be the most authoriative access for the community to get to understand the pharmacoeconomincs. |
